1-3 of 3
Ron de Jong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3945: Novel antagonists of TEAD palmitoylation inhibit the growth of Hippo-altered cancers in preclinical models

Adeela Kamal, Aurélie Candi, Matthias Versele, Bart Vanderhoydonck, Arnaud Marchand, Ron de Jong, Thuy Hoang, Georg Halder, Patrick Chaltin, Stephen L. Gwaltney, Mike Burgess
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3945.
https://doi.org/10.1158/1538-7445.AM2022-3945
Published: 15 June 2022
View article titled, Abstract 3945: Novel antagonists of TEAD palmitoylation inhibit the growth of Hippo-altered cancers in preclinical models
Journal Articles

Abstract 5676: Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-Ribose)polymerase inhibitors.

Anthony R. Gangloff, Jason Brown, Ron De Jong, Philip Erickson, Charles Grimshaw, Mark Hixon, Andy Jennings, Ruhi Kamran, Andre Kiryanov, Shawn O'Connell, Ewan Taylor, Phong Vu
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5676.
https://doi.org/10.1158/1538-7445.AM2013-5676
Published: 15 April 2013
View article titled, Abstract 5676: Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-Ribose)polymerase inhibitors.
Journal Articles

Crkl Enhances Leukemogenesis in BCR/ABL P190 Transgenic Mice

Bianca Hemmeryckx, Arnoud van Wijk, Anja Reichert, Vesa Kaartinen, Ron de Jong, Paul K. Pattengale, Ignacio Gonzalez-Gomez, John Groffen, Nora Heisterkamp
Journal: Cancer Research
Cancer Res (2001) 61 (4): 1398–1405.
Published: 02 February 2001
View article titled, Crkl Enhances Leukemogenesis in <em>BCR/ABL</em> P190 Transgenic Mice
Open the PDF for Crkl Enhances Leukemogenesis in <em>BCR/ABL</em> P190 Transgenic Mice in another window